Search results
Tracking down the genetic causes of lupus to personalize treatment - Berkeley News
UC Berkeley NewsCenter· 3 days agoLupus is a lifelong, often painful and occasionally lethal autoimmune disease. Few treatments exist today beyond powerful steroids to knock down a patient’s immune system ...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 4 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Study Identifies Several Onychomycosis Risk Factors
Medscape· 7 days agoTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in...
How Does AI Fit Into Clinical Practice?
Medscape· 6 days agoRandomized studies on AI seem to be concentrated in gastroenterology, radiology, surgery, and cardiology, with less emphasis on primary care.
Is TikTok’s #sunbedaddiction the most dangerous trend on social media today?
Harpers BAZAAR· 3 days agoTikTok beauty trends can span the good (heatless styling), the bad (sunscreen contouring) and the...
Tracking down the genetic causes of lupus to personalize treatment
Medical Xpress· 3 days agoResearchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies to those who will benefit most. In the latest advance ...
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 5 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
Got Tiny Blood Vessels on Your Face? Here's Why, and How To Treat Them
Well and Good· 5 days agoMore often than not, those red, spider-like clusters are just...broken blood vessels. Broken blood...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 3 days agoIn these studies, bimekizumab consistently demonstrated sustained improvements...
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 15 hours agoStock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the ...